Shankar Lal Rampal Dye Chem Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 30, 2026

Key Highlights

The Latest Trading Price of Shankar Lal Rampal Dye-Chem Ltd is ₹ 39.03 as of 30 Mar 15:30 . The P/E Ratio of Shankar Lal Rampal Dye-Chem Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Shankar Lal Rampal Dye-Chem Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Shankar Lal Rampal Dye-Chem Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Shankar Lal Rampal Dye-Chem Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Shankar Lal Rampal Dye-Chem Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Shankar Lal Rampal Dye-Chem Ltd changed from 1.4 % on March 2021 to 2.81 % on March 2025 . This represents a CAGR of 14.95% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Shankar Lal Rampal Dye-Chem Ltd

Shankar Lal Rampal Dye-Chem Limited was originally constituted as a Private Limited Company in the name and styles of 'M/s.
Shankar Lal Rampal Dye-Chem Private Limited' vide an Incorporation Certificate on September 19, 2005.
Subsequently, it was converted into a Public Limited Company and the name of the Company was changed to 'Shankar Lal Rampal Dye-Chem Limited' vide a fresh Certificate of Incorporation dated May 08, 2018 issued by Registrar of Companies, Jaipur. The Company has made a prominent mark for itself in the Chemical industry, since its incorporation in 2005.
The Company's business in the trading of Dyes and Chemicals was started by Late Shree Shankar Lal Inani in 2005.
Based in Bhilwara (Rajasthan), the Company is named as a prominent Trader, Exporter, Importer, and Supplier of Sodium Sulphide flakes Red and Yellow, Soduim Hydro Sulphite , Hydrogen Peroxide, Citric Acid Monohydrate / Anhydrous, Phosphate Chemicals-sodium Hexameta phosphate, Sodium Tripoly phosphate, Tri Sodium Phosphate, Sodium Nitrite, and Refined Glycerine in India.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Shankar Lal Rampal Dye-Chem Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Shankar Lal Rampal Dye-Chem Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Shankar Lal Rampal Dye-Chem Ltd is 249 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,458 Cr

What are the key factors driving the stock performance of Shankar Lal Rampal Dye-Chem Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Shankar Lal Rampal Dye-Chem Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shankar Lal Rampal Dye-Chem Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 30, 2026, the Shankar Lal Rampal Dye-Chem Ltd stock price is INR ₹39.03. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1050.9.

How do dividend payouts of Shankar Lal Rampal Dye-Chem Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Shankar Lal Rampal Dye-Chem Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.